127 related articles for article (PubMed ID: 20980962)
1. Immunosuppressive regimen and prevalence of chronic kidney disease in orthotopic heart transplant recipients.
Przybylowski P; Malyszko J; Malyszko J
Med Sci Monit; 2010 Nov; 16(11):CR563-6. PubMed ID: 20980962
[TBL] [Abstract][Full Text] [Related]
2. The natural history of renal function following orthotopic heart transplant.
Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of chronic kidney disease is extremely high in heart transplant recipients.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2009 Oct; 41(8):3239-41. PubMed ID: 19857720
[TBL] [Abstract][Full Text] [Related]
4. Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients.
Israni A; Brozena S; Pankewycz O; Grossman R; Bloom R
Am J Kidney Dis; 2002 Mar; 39(3):E16. PubMed ID: 11877596
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease after heart transplantation.
Hamour IM; Omar F; Lyster HS; Palmer A; Banner NR
Nephrol Dial Transplant; 2009 May; 24(5):1655-62. PubMed ID: 19168463
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of chronic kidney disease in orthotopic heart transplant recipients and kidney allograft recipients using the new Chronic Kidney Disease Epidemiology Collaboration formula.
Malyszko J; Przybylowski P; Malyszko JS; Iaina-Levin N; Sadowski J; Mysliwiec M
Transplant Proc; 2010 Dec; 42(10):4251-4. PubMed ID: 21168676
[TBL] [Abstract][Full Text] [Related]
7. Long-term renal function in heart transplant recipients receiving cyclosporine therapy.
Goral S; Ynares C; Shyr Y; Yeoh TK; Johnson HK
J Heart Lung Transplant; 1997 Nov; 16(11):1106-12. PubMed ID: 9402509
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation.
Campbell KM; Yazigi N; Ryckman FC; Alonso M; Tiao G; Balistreri WF; Atherton H; Bucuvalas JC
J Pediatr; 2006 Apr; 148(4):475-80. PubMed ID: 16647407
[TBL] [Abstract][Full Text] [Related]
10. Long-term glomerular filtration rate in liver allograft recipients according to the type of calcineurin inhibitors.
Niel OR; Berthoux F; Albano L; Dahan P; Aoudia R; Gugenheim J; Cassuto E
Transplant Proc; 2009 Oct; 41(8):3329-32. PubMed ID: 19857743
[TBL] [Abstract][Full Text] [Related]
11. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
12. Renal function outcome in pediatric liver transplant recipients.
Mention K; Lahoche-Manucci A; Bonnevalle M; Pruvot FR; Declerck N; Foulard M; Gottrand F
Pediatr Transplant; 2005 Apr; 9(2):201-7. PubMed ID: 15787794
[TBL] [Abstract][Full Text] [Related]
13. Five years' follow-up of renal glomerular and tubular functions in heart transplant recipients.
Hartmann A; Andereassen AK; Holdaas H; Simonsen S; Geiran O; Berg KJ
J Heart Lung Transplant; 1996 Oct; 15(10):972-9. PubMed ID: 8913913
[TBL] [Abstract][Full Text] [Related]
14. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.
Marcén R; del Castillo D; Capdevila L; Fernandez-Fresnedo G; Rodrigo E; Cantarell C; Fernández-Rodriguez A; López-Oliva MO; Camps J; Aljama P; Ortuño J; Arias M
Transplantation; 2009 May; 87(9):1340-6. PubMed ID: 19424034
[TBL] [Abstract][Full Text] [Related]
15. Challenges in pediatric transplantation: the impact of chronic kidney disease and cardiovascular risk factors on long-term outcomes and recommended management strategies.
Filler G
Pediatr Transplant; 2011 Feb; 15(1):25-31. PubMed ID: 21155958
[TBL] [Abstract][Full Text] [Related]
16. Overview of tacrolimus-based immunosuppression after heart or lung transplantation.
Reichenspurner H
J Heart Lung Transplant; 2005 Feb; 24(2):119-30. PubMed ID: 15701425
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
[TBL] [Abstract][Full Text] [Related]
18. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
Raichlin E; Khalpey Z; Kremers W; Frantz RP; Rodeheffer RJ; Clavell AL; Edwards BS; Kushwaha SS
Transplantation; 2007 Aug; 84(4):467-74. PubMed ID: 17713429
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients.
Kim SJ; Prasad GV; Huang M; Nash MM; Famure O; Park J; Thenganatt MA; Chowdhury N; Cole EH; Fenton SS; Cattran DC; Zaltzman JS; Cardella CJ
Transplantation; 2006 Oct; 82(7):924-30. PubMed ID: 17038908
[TBL] [Abstract][Full Text] [Related]
20. Renal function in pediatric liver transplantation: a long-term follow-up study.
Harambat J; Ranchin B; Dubourg L; Liutkus A; Hadj-Haïssa A; Rivet C; Boillot O; Lachaux A; Cochat P
Transplantation; 2008 Oct; 86(8):1028-34. PubMed ID: 18946339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
